Clinical Microbiology: Open Access

Antimicrobials and COVID-19: Strategies for Treating a Pandemic

Antimicrobials and COVID-19: Strategies for Treating a Pandemic

Early protection, early identification, early diagnosis, and early isolation are crucial to combat with Covid-19 outbreaks. 

Chloroquine, a medication on the WHO model list of esential medicines, and hydroxychloroquine, its subordinate, as conceivable treatment choices for the novel coronavirus, SARS-CoV-2. Positive results from preliminary studies indicate that hydroxychloroquine, an antimalarial drug, has the potential to improve disease outcomes and possibly slow COVID-19’s progression. However, officials stated that additional data are needed before the drug can be approved as an effective treatment for the disease. 

To publish the most exciting research with respect to the subjects of Antimicrobials and COVID-19 and to provide a rapid turn-around time regarding reviewing and publishing, and to disseminate the articles freely for research, teaching and reference purposes.

Clinical Microbiology: Open Access invites you to submit your research work via our Online Editorial Tracking System https://www.longdom.org/submissions/clinical-microbiology-open-access.html or through E-mail at clinmicrobiology@escienceopen.com . Make sure that submitted manuscript should not have been submitted or published previously anywhere else for publication. It is strictly advised to submit original and plagiarism free articles.